Skip to main content



) --




) hit a new 52-week high Thursday as it is currently trading at $85.80, above its previous 52-week high of $85.74 with 954,467 shares traded as of 12:15 p.m. ET. Average volume has been two million shares over the past 30 days.

Allergan has a market cap of $25.8 billion and is part of the

health care

sector and


industry. Shares are up 22.5% year to date as of the close of trading on Wednesday.

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific.

  • Practice your AGN trading strategies and win cash in our stock game.

TheStreet Ratings rates Allergan as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full

Allergan Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center